logo
Stay safe when the temperatures rise

Stay safe when the temperatures rise

Yahoo17-05-2025
SAVANNAH, Ga (WSAV) — A hot weekend is ahead of us, a scorcher some may say.
Dr Jay Goldstein with Memorial Health said one of the top medical concerns is heat stroke, with heat exhaustion being the most common.
'When we start seeing the heat waves, the first and second heat waves into our communities is when we see the most effect on these consumers because they're not acclimated and they believe they can still perform at the same level and the same amount of exercise and not realize the signs and the effects that the heat is getting to them,' Dr. Goldstein said.
'You're starting to get heat exhaustion in the sun and the weather, and the elements are starting to get to you. and so, when you get to that element of heat stroke, your body temperature rises significantly.'
Goldstein broke it down even more, highlighting why one is far more dangerous.
'So, heat exhaustion is where you're out on a tennis court, you're maybe not acclimated to the weather and you start feeling a little bit overheated, a little bit thirsty and lightheaded,' Goldstein said. 'Heat stroke is where your body temperature rises to extreme levels, and you can't bring it down. And if you don't seek immediate and urgent decrease in temperature, you could die from that.'
How can we take care of our body as we head into the hotter months? Dr. Goldstein laid out a plan.
'So, the first thing I would tell you is alcohol and caffeine can affect you. And they actually can be kind of more diuretic,' he said. 'They'll cause you to urinate out more than you actually take in. We believe in a balanced electrolyte approach. So, drink a Gatorade and then follow it up with water or drink a half of Gatorade and then fill it back up with water.'
Dr. Goldstein also said you can't forget about your skin when having fun. You want to start with sunscreen with SPF 15.
'Realize that the sun has very damaging effects, either sunburn, heat, illness, cancer later in life. So, we want to make sure that you are wearing your sunscreen.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ImmunityBio's (IBRX) ANKTIVA Gets Approved by UK's Medicines and Healthcare Regulatory Agency
ImmunityBio's (IBRX) ANKTIVA Gets Approved by UK's Medicines and Healthcare Regulatory Agency

Yahoo

timea few seconds ago

  • Yahoo

ImmunityBio's (IBRX) ANKTIVA Gets Approved by UK's Medicines and Healthcare Regulatory Agency

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the . On July 8, ImmunityBio, Inc. (NASDAQ:IBRX) announced that the UK's Medicines and Healthcare products Regulatory Agency has approved ANKTIVA with Bacillus Calmette-Guérin for treating certain bladder cancer patients. This is significant as it marks the first approval for the company outside of the United States of America. Moreover, the drug is a first-in-class IL-15 agonist, which works by activating and multiplying immune cells, specifically NK cells and T cells that help the body fight cancer. A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents. In addition, clinical studies have shown strong results as some patients maintained a complete response for over 47 months at the last review. ImmunityBio, Inc. (NASDAQ:IBRX) is a biopharmaceutical company that develops therapies and vaccines that boost the immune system to fight cancer and infectious diseases. While we acknowledge the potential of IBRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Citi Maintained a Buy Rating on Sana Biotechnology (SANA)
Citi Maintained a Buy Rating on Sana Biotechnology (SANA)

Yahoo

timea few seconds ago

  • Yahoo

Citi Maintained a Buy Rating on Sana Biotechnology (SANA)

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the . On July 2, Citi analyst Samantha Semenkow maintained a Buy rating on Sana Biotechnology, Inc. (NASDAQ:SANA) with a price target of $15. The analyst believes the company has the potential to address major market needs. One of the key factors is Sana Biotechnology, Inc.'s (NASDAQ:SANA) Type 1 Diabetes (T1D) program, which has delivered encouraging six-month data. The data shows successful graft survival and steady c-peptide production without requiring immunosuppression. The analyst noted that such consistency builds confidence in the company's T1D asset, SC451, which could move toward an IND filing as early as 2026. A scientist working with a microscope in a laboratory, focusing on a cell of a medical experiment. Moreover, Semenkow also highlighted the company's progress in its allogeneic CAR-T platform. She expects forthcoming data on the hypoimmune-modified CAR-T assets to provide important insights, particularly those targeting autoimmune diseases and relapsed NHL. Sana Biotechnology, Inc. (NASDAQ:SANA) develops engineered cell-based medicines to treat diseases with unmet needs. The company's work focuses on therapies for type 1 diabetes, autoimmune diseases, and cancer. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer
LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer

Yahoo

timea few seconds ago

  • Yahoo

LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer

LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the . On May 14, LifeStance Health Group, Inc. (NASDAQ:LFST) announced appointing Vaughn Paunovich as Chief Technology Officer, effective June 9, 2025. Paunovich will oversee all technology initiatives at LifeStance Health Group, Inc. (NASDAQ:LFST), while strengthening digital platforms for both patients and clinicians. Dave Bourdon, the CEO, praised Paunovich's history of leading top technology teams. He brings over 25 years of experience in health care technology and has previously worked at Amwell as EVP of Enterprise Platforms and held senior technology roles at UnitedHealth Group and Optum Health. A close-up of a healthcare professional studying a computer screen with data while consulting with a patient. LifeStance Health Group, Inc. (NASDAQ:LFST) provides virtual and in-person outpatient mental health care for children, adolescents, and adults. While we acknowledge the potential of LFST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store